Cucurbitacin E, a compound in herbal extracts, can inhibit tumour angiogenesis by inhibiting vascular endothelial growth factor receptor 2- (KDR/VEGFR2-) mediated Jak-STAT3 and mitogen-activated protein kinase (MAPK) signalling pathways [26]. The gene discussed is KDR; the disease is neoplasm.